DTDominic M. Taylor

Dominic M. Taylor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dominic M. Taylor has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for decline in estimated glomerular filtration rate amongst Malawian adults living in rural Karonga: Protocol for a prospective cohort study using cystatin C- and creatinine-based eGFR

    by Charlotte M. Snead, Chimwemwe Mkandawire, Paul Kambiya, Shekinah Munthali-Mkandawire, Fredrick Kalobekamo, Albert Dube, Thandile Nkosi-Gondwe, Baltazar Bananga Mtenga, Dominic Nzundah, Lenford Kamkwanya, et al.

    Background: The global burden of chronic kidney disease (CKD) is rising, disproportionately impacting on low- and middle-income countries. In African populations, use of serum creatinine to estimate glomerular filtration rate (GFR) significantly underestimates CKD prevalence, contributing to its under-recognition as a health problem. Serum cystatin C provides more accurate estimates of Iohexol measured GFR than creatinine. Early diagnosis and treatment of CKD is essential to reduce premature morbidity and mortality. However, little is known about risk factors for CKD development and progression in Africa owing to limited longitudinal data. This study aims to determine risk factors for progressive kidney function decline among adults living in rural, northern Malawi. Methods: This protocol describes a prospective study being conducted in a general population Health and Demographic Surveillance Site in rural Karonga, Malawi (2024–2025). Eligible participants are adults aged 18 years and over who participated in two population-based surveys of long-term health conditions (2013–2016 and 2021–2025), with availability of baseline measures. New household-level data is being prospectively collected on CKD risk factors, alongside blood and urine samples. Cystatin C and creatinine will be tested on individual-level paired, stored serum samples collected at three longitudinal time points. Urine will undergo dipstick urinalysis, microscopy and testing for albumin and creatinine to quantify proteinuria. The primary outcome will be sustained 25% reduction in estimated GFR (eGFR) from baseline and change in eGFR category, determined using serum cystatin C. Multivariable logistic regression will be used to determine effect size estimates of key risk factors for kidney function decline. Discussion: This study will provide important data on risk factors for eGFR decline and CKD progression amongst Malawian adults. The findings will inform future research into important context-specific risk factors, and could directly inform health policies in Malawi for targeting CKD screening, prevention and treatment strategies to high-risk patient groups.

  • Open Access

    Risk factors for long-term decline in kidney function amongst Malawian adults living in rural Karonga: protocol for a prospective cohort study

    by Charlotte May Snead, Chimwemwe Mkandawire, Paul Kambiya, Shekinah Munthali-Mkandawire, Fredrick Kalobekamo, Albert Dube, Thandile Nkosi-Gondwe, Baltazar Bananga Mtenga, Dominic Nzundah, Lenford Kwamkwanya, et al.

    Background: The global burden of chronic kidney disease (CKD) is rising, disproportionately impacting on low- and middle-income countries. In African populations, use of serum creatinine to estimate glomerular filtration rate (GFR) significantly underestimates CKD prevalence, contributing to its under-recognition as a health problem. Serum cystatin C provides more accurate estimates of Iohexol measured GFR than creatinine. Early diagnosis and treatment of CKD, targeted towards high-risk individuals, is essential to reduce premature morbidity and mortality. However, little is known about risk factors for CKD development and progression in Africa owing to limited longitudinal data. This study aims to determine risk factors for progressive kidney function decline among adults living in rural, northern Malawi. Methods: This protocol describes an ongoing prospective study being conducted in a general population cohort in rural Karonga, Malawi. We are recruiting adults aged 18 years and over who participated in two previous population-based surveys of long-term health conditions, over five years apart. New household-level data is being collected on CKD risk factors, alongside blood and urine samples. Cystatin C and creatinine will be tested on individual-level paired, stored serum samples collected at three longitudinal time points. Urine will undergo dipstick urinalysis, microscopy and testing for albumin and creatinine to quantify proteinuria. The primary outcome will be sustained 25% reduction in estimated GFR (eGFR) from baseline and change in eGFR category, determined using serum cystatin C. Multivariable logistic regression will be used to determine effect size estimates of key risk factors for kidney function decline. Discussion: This study will provide important data on risk factors for eGFR decline and CKD progression amongst Malawian adults. The findings will inform future research into important context-specific risk factors, and could directly inform future health policies in Malawi for targeting CKD screening, prevention and treatment strategies to the highest risk patient groups.

  • Open Access

    Defining normal serum creatinine in pregnancy—results from the AKID UK prospective cohort study

    by Laura Skinner, Kate Birnie, Katie A Mettam, Judith P Standing, Amy E Howell, Erik Lenguerrand, Abigail Fraser, Alison J Armitage, Christy Burden, Dominic M Taylor

    Background: Abnormal kidney function in pregnancy may represent chronic kidney disease or pregnancy-associated acute kidney injury, both associated with adverse outcomes during and after pregnancy. Serum creatinine remains the standard biomarker for kidney function in pregnancy, but normal levels change dynamically through pregnancy and at term. Existing gestation-specific reference ranges for serum creatinine and recommendations to investigate for abnormal kidney function in pregnancy are based on limited data. Data describing trajectories of serum creatinine through pregnancy and the normal, physiological increase in serum creatinine at term are also lacking. Methods: We recruited 476 healthy pregnant individuals aged 16 years or over, 2019–21, measuring serum creatinine in the first, second and third trimesters of pregnancy, at birth and postpartum. Clinical data were abstracted. Gestation-specific reference ranges for serum creatinine were defined as mean ± 1.96 × SD, after excluding those with adverse pregnancy outcomes. Trajectories of serum creatinine through pregnancy, and the change in serum creatinine at delivery were described. Results: 1875 creatinine measurements were recorded. Reference ranges for serum creatinine in the first, second and third trimesters of healthy pregnancy were 37–67 μmol/l (0.42–0.75 mg/dl), 34–63 μmol/l (0.38–0.71 mg/dl), and 34–66 μmol/l (0.39–0.75 mg/dl). Increasing serum creatinine in early pregnancy was more common in those with hypertensive disorders of pregnancy, prior to disease onset. In healthy participants, median serum creatinine increase from 36 weeks to birth was 6.8% (95% CI 4.5%, 9.1%). Conclusions: Investigation for abnormal kidney function in pregnancy should be considered at a lower creatinine threshold than currently recommended. Detecting abnormal creatinine trajectories may help early identification of high-risk pregnancies.


  • Open Access

    An introduction to realist evaluation and synthesis for kidney research

    by Dominic M. Taylor, Ailish M.S. Nimmo, Barnaby Hole, G.J. Melendez-Torres


  • Complex Interventions Across Primary and Secondary Care to Optimize Population Kidney Health

    by Dominic M. Taylor, Ailish M. Nimmo, Fergus J. Caskey, Rachel Johnson, Maria Pippias, G.J. Melendez-Torres

    Background: CKD affects 850 million people worldwide and is associated with high risk of kidney failure and death. Existing, evidence-based treatments are not implemented in at least a third of eligible patients, and there is socioeconomic inequity in access to care. While interventions aiming to improve delivery of evidence-based care exist, these are often complex, with intervention mechanisms acting and interacting in specific contexts to achieve desired outcomes. Methods: We undertook realist synthesis to develop a model of these context-mechanism-outcome interactions. We included references from two existing systematic reviews and from database searches. Six reviewers produced a long list of study context-mechanism-outcome configurations based on review of individual studies. During group sessions, these were synthesized to produce an integrated model of intervention mechanisms, how they act and interact to deliver desired outcomes, and in which contexts these mechanisms work. Results: Searches identified 3371 relevant studies, of which 60 were included, most from North America and Europe. Key intervention components included automated detection of higher-risk cases in primary care with management advice to general practitioners, educational support, and non–patient-facing nephrologist review. Where successful, these components promote clinician learning during the process of managing patients with CKD, promote clinician motivation to take steps toward evidence-based CKD management, and integrate dynamically with existing workflows. These mechanisms have the potential to result in improved population kidney disease outcomes and cardiovascular outcomes in supportive contexts (organizational buy-in, compatibility of interventions, geographical considerations). However, patient perspectives were unavailable and therefore did not contribute to our findings. Conclusions: This systematic review and realist synthesis describes how complex interventions work to improve delivery of CKD care, providing a framework within which future interventions can be developed. Included studies provided insight into the functioning of these interventions, but patient perspectives were lacking in available literature. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_05_08_CJN0000000000000136.mp3


  • Barriers to Living Kidney Donation

    by Ailish Nimmo, Dominic Taylor, Pippa Bailey

  • Open Access

    P1633STANDARDIZED REVIEW OF DONOR AFTER BRAIN DEATH KIDNEY OFFERS; A QUALITY IMPROVEMENT PROJECT

    by Amy Riddell, Deborah Munro, Lins Varughese, Anusha Edwards, Samuel Turner, Dominic Taylor

    Background and Aims: Transplanting renal centres have a duty to use the finite resource of the deceased-donor kidney pool to benefit potential recipients without exposing them to excessive risk. However, there is known variation in centre and clinician practice. This may relate to clinicians’ attitude to risk, knowledge of the recipient and unit culture. Centre differences in acceptability of donor organs is evidenced by variation in NHS blood and transplant registry data. Use of marginal donors has become more frequent, especially for older recipients with higher comorbidity. In the UK this year we will see whether switching to an ‘opt out’ donation law further increases this proportion of donors. We developed a systematic method to retrospectively review donation after brain death (DBD) kidney offers declined by our centre, with the intention of reducing variation in practice between clinicians, and identifying cases where offer acceptance may have been appropriate Method: All DBD kidney offers declined by the Richard Bright Renal Service between June 2018 and May 2019 were reviewed. Data were collected by casenotes review and by contact with other transplanting units to establish the outcome of donor kidneys and recipient progress. Reasons for offer decline were recorded. Donor and recipient risk indices (DRI and RRI) were calculated. For patients now transplanted, the DRI of the declined offer was compared to the DRI of the transplanted kidney. Results: During the study period, 98 DBD kidneys were declined. A donor organ identifier was not available in 8 cases, so 90 are considered here. Average donor age was 57 years with 52% having a Donor Risk Index (DRI) score of 4, and 74.7% a DRI score ≥3. The most common reasons for organ decline were donor related (65%), of which 27% were due to poor kidney function and 22% age mismatch; or recipient related (35%), where 30% were deemed inadequate quality for the recipient and 30% were unavailable or unwell. Of those kidneys which were transplanted elsewhere, 88% were functioning at 6 months with a median creatinine of 119 (IQR 106-148). There were 60 potential recipients, 61% of whom had a RRI score ≥3; 44% had a RRI equal to or less than the DRI of the declined organ. Those who have still not been transplanted have accrued a median of 352 extra days on dialysis. 31 recipients (52%) have been transplanted since their declined offer. The median change in DRI score from the declined offer to the accepted offer was -1 (IQR -2 to 1), and offers were accepted after a median of 45 (IQR 14-143) additional dialysis days. Of those who were transplanted after declining a donor offer, 11 (39%) received a kidney from a donor with equal or worse DRI than the original offer, after a median of 49 further days on dialysis. Conclusion: This review process highlights the effect of kidney offer decline on future progress of the potential recipient, as well as differences in our centre practice compared to other centres. Key to this review is to highlight the risks involved with DBD organ decline- 18% of recipients ultimately received an equal or inferior kidney while accruing additional time on dialysis. Alongside this review we have implemented strategies including a policy on AKI in donors and monthly multidisciplinary meetings to discuss individual DBD decline cases. We aim to standardize decision making and increase our utilization of all as well as marginal DBD organs, and expect to show a reduction in variation in practice in future reviews. Use of this process in other units or at a national level could reduce unwarranted variation in the utilization of the donor organ pool.

  • Limited health literacy is associated with reduced access to kidney transplantation

    by Dominic M. Taylor, J. Andrew Bradley, Clare Bradley, Heather Draper, Christopher Dudley, Damian Fogarty, Simon Fraser, Rachel Johnson, Geraldine M. Leydon, Wendy Metcalfe, et al.


  • Top Cited Papers

    Health literacy and patient outcomes in chronic kidney disease: a systematic review

    by Dominic M Taylor, Simon Fraser, Chris Dudley, Gabriel C Oniscu, Charles Tomson, Rommel Ravanan, Paul Roderick, the ATTOM investigators

    Background: Limited health literacy affects 25% of people with chronic kidney disease (CKD), and may reduce self-management skills resulting in poorer clinical outcomes. By disproportionately affecting people with low socio-economic status and non-white ethnicity, limited health literacy may promote health inequity. Methods: We performed a systematic review of quantitative studies of health literacy and clinical outcomes among adults with CKD. Results: A total of 29 studies (13 articles; 16 conference abstracts) were included. One included non-USA patients. Of the 29 studies, 5 were cohort studies and 24 were cross-sectional. In all, 18 300 patients were studied: 4367 non-dialysis CKD; 13 202 dialysis; 390 transplant; 341 unspecified. Median study size was 127 [interquartile range (IQR) 92–238)], but 480 (IQR 260–2392) for cohort studies. Median proportion of non-white participants was 48% (IQR 17–70%). Six health literacy measures were used. Outcomes included patient attributes, care processes, clinical/laboratory parameters and ‘hard’ clinical outcomes. Limited health literacy was significantly, independently associated with hospitalizations, emergency department use, missed dialysis sessions, cardiovascular events and mortality (in cohort studies). Study quality was high (1 study), moderate (3 studies) and poor (25 studies), limited by sampling methods, variable adjustment for confounders and reduced methodological detail given in conference abstracts. Conclusions: There is limited robust evidence of the causal effects of health literacy on patient outcomes in CKD. Available evidence suggests associations with adverse clinical events, increased healthcare use and mortality. Prospective studies are required to determine the causal effects of health literacy on outcomes in CKD patients, and examine the relationships between socio-economic status, comorbidity, health literacy and CKD outcomes. Intervention development and evaluation will determine whether health literacy is a modifiable determinant of poor outcomes in CKD.


  • Open Access

    Complications of bone metastases from malignant melanoma

    by Jamal Zekri, Maria Marples, Dominic Taylor, Kiran Kandukurti, Lucy McParland, Janet E. Brown